Breadcrumbs Home News & Events Press Releases Press Releases Year All202520242023202220212020201920182017201620152014201320122011201020092008 Type AllRegulatoryNon-regulatory Jul 13, 2020 BioInvent to host Key Opinion Leader call on enhancing checkpoint inhibitors for the treatment of solid cancers Jul 09, 2020 BioInvent's Board of Directors resolve on a repair rights issue of a maximum of approx. SEK 139 million, following the successfully completed directed share issue of approx. SEK 487 million Jul 08, 2020 BioInvent publishes prospectus regarding admission to trading of newly issued shares on Nasdaq Stockholm Jul 03, 2020 Resolutions at the Extraordinary General Meeting in BioInvent on July 3, 2020 Jul 01, 2020 BioInvent extends research collaboration and license agreement with Pfizer Inc. Jun 30, 2020 BioInvent submits a CTA for a Phase I/IIa trial of BI-1808, a first-in-class anti-TNFR2 antibody for the treatment of patients with solid tumors and CTCL Pagination First page Previous page … Page 31 Current page 32 Page 33 Page 34 … Next page Last page
